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Introduction
On the fiftieth anniversary of the landmark 1964 US Surgeon General's Report on Smoking and Health (US Department of Health E., and Welfare, 1964) , the 2014 Surgeon General's report concludes that, while all forms of tobacco use are unsafe, cigarette smoking: (1) accounts for 480,000 deaths; (2) remains the number one preventable cause of premature death; (3) causes diabetes and multiple cancers including colorectal and liver cancers; and (4) leads to $289 billion in healthcare and lost productivity costs annually in the US alone (CDC, 2014) . The decline in the smoking prevalence has slowed in recent years, with 42 million Americans still smoking.
States' funding for population-level smoking cessation programs (e.g., quitlines) remains far below CDC-recommended levels. Consequently, there is a tremendous need for interventions with strong potential population-level impact at the lowest possible cost (CDC, 2014).
New technology: Smoking cessation apps
That potential can be found in the newest technological innovation in quit smoking interventions: smartphone-based smoking cessation software applications ("apps"; Abroms et al., 2011 Abroms et al., , 2013 Buller et al., 2013) . Smartphones apps have all of the beneficial features of websites and text messaging interventions, but without their limitations (Abroms et al., 2013; Buller et al., 2013; Chen et al., 2012) . Specifically, smartphone apps can have these important features: (1) available at arm's reach, (2) visually-engaging design, (3) video and audio capabilities, (4) unrestricted text capabilities, (5) access without cellular or internet connection, (6) immediate http://dx.doi.org/10.1016/j.drugalcdep.2014.07.006 0376-8716/© 2014 Elsevier Ireland Ltd. All rights reserved. No. of Pages 8 access to intervention content, (7) optimized to smartphone screen size, (8) content sharable via social media, and (9) tracking progress anywhere and anytime. Indeed, apps are an important technological advance over web sites and text messaging programs because of their high potential to boost user engagement-a consistently strong predictor of smoking cessation (Civljak et al., 2010; Shahab and McEwen, 2009; Webb, 2009; Whittaker et al., 2012) .
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Apps' reach and effectiveness
Smoking interventions' population-level impact is driven by the number of smokers they reach and their effectiveness. Smartphone apps for smoking cessation now have enormous reach. In 2013, there were over 400 smoking cessation apps (Abroms et al., 2013) . In March 2014, using the xyo.net app search engine, we found a total of 546 English language smoking cessation apps in the Apple Store and Google Play that were downloaded to smartphones an estimated 3.2 million times in the United States and 20 million times worldwide. By contrast, during 2012-2013, there were an estimated 1 million enrollments to US tobacco quitlines (Consortium, 2013; Leischow et al., 2012) and an estimated 140,000 total subscriptions to US text messaging programs (L. Abroms, personal communication, March 4, 2014; E. Augustson, personal communication, March 4, 2014) .
The reach of smoking cessation apps is climbing rapidly, greatly aided by the growing ownership of smartphones. The majority (58%) of US adults now own smartphones (Smith, 2013) , and ownership is projected to reach at least 90% by 2020 (Dediu, 2013; Statista, 2014) . Importantly, minority ownership is strong, with 64% of African Americans and 60% of Hispanics now owning smartphones, as compared to 53% for Caucasians (Smith, 2013) . The greatest ownership growth rate is among those with low incomes (Nielsen, 2013; Smith, 2013) . The current and projected demographics of smartphone ownership suggest that this treatment modality could address known tobacco-related health disparities associated with race/ethnicity and socioeconomic status (Fagan et al., 2004) .
The effectiveness of smartphone apps for smoking cessation is largely unknown. Except for a pilot trial of young adults (Buller et al., 2013) , no randomized trials of their effectiveness for general adult cessation have been published. The contrast between smoking cessation apps' high usage and their lack of effectiveness data is a serious scientific gap that could stifle their population-level impact.
The current standard in smoking cessation interventions is the US Clinical Practice Guidelines (USCPG). The USCPG have the following essential content: tracking smoking status, offering quit planning, advice on pharmacotherapy, tools to enhance motivation, and social support for quitting (Fiore et al., 2008) . Of the apps now available, a small minority follow the USCPG (Abroms et al., 2011 (Abroms et al., , 2013 . However, just following the USCPG is likely insufficient. For example, multiple recent meta-analyses of websites and of text messaging interventions that follow USCPG report that their average intent-to-treat 30-day point prevalence quit rates at 12 months post-randomization are remarkably similar, ranging from 7% to 10% (Civljak et al., 2010; Hutton et al., 2011; Shahab and McEwen, 2009; Whittaker et al., 2012) . Consequently, an app that goes a key step beyond the USCPG through innovative theory-based intervention content has promise to produce higher quit rates.
ACT: An emerging theory-based intervention
To start a smartphone research paradigm focusing on innovative intervention content, the current study will compare an app that follows USCPG with one that adds novel content based on a behavior change model called acceptance and commitment therapy (ACT; Hayes et al., 2006) . ACT focuses on increasing willingness to experience physical cravings, emotions, and thoughts while making values-guided committed behavior changes. In ACT, acceptance means making room for intense physical cravings (e.g., urges to smoke), emotions (e.g., sadness that triggers smoking), and thoughts (e.g., thoughts that trigger smoking) while allowing them to come and go. Commitment in ACT means articulating what is deeply meaningful to individuals -i.e., their values -to motivate and guide specific plans of action (e.g., stopping smoking). Numerous studies have supported the effectiveness of ACT for a wide variety of problems including depression and drug addiction (Hayes et al., 2006 (Hayes et al., , 2013 .
This study
This study addressed the dual needs for (1) innovative theorybased intervention content and (2) controlled trials to evaluate the efficacy of apps for smoking cessation. Accordingly, we developed the first smartphone app-delivered ACT intervention for smoking cessation, called "SmartQuit." We then conducted a nationallyrecruited randomized, controlled pilot trial comparing SmartQuit with the National Cancer Institute's QuitGuide app. The aims were to determine (1) trial design feasibility, (2) participant receptivity and satisfaction, (3) preliminary cessation outcomes overall and for two key subgroups (those reporting: (a) heavy smoking; (b) low acceptance of cravings), and (4) potential impact on acceptance of cravings to smoke-ACT's theory-based process of change.
Methods
Participants
Eligibility criteria: (1) age 18 or older; (2) smokes at least five cigarettes daily for at least past 12 months, as consistent with cessation trials (Civljak et al., 2010) ; (3) wants to quit in the next 30 days; (4) interested in learning skills to quit smoking; (5) willing to be randomly assigned to either smartphone application; (6) resides in US; (7) knows how to download a smartphone application from Apple's App Store; (8) willing and able to read English; (9) not using other smoking cessation interventions (including apps and our other intervention studies); and (10) has at least daily access to their own Apple iPhone 4, 4s, or 5. The iPhone was chosen as the singular smartphone platform for the study because it provided the technical simplicity of only one type of hardware to run the app, and thereby freed up limited resources for programming. Participants not eligible for or interested in randomization were given information on alternative treatment to help them quit.
Procedures
All study procedures were reviewed and approved by the Fred Hutchinson Cancer Research Center Institutional Review Board.
Sample size
As Aim 1's focus was on feasibility, the study's sample size was powered to show differences in engagement, operationalized as the number of times participants opened their assigned app. Extrapolating from our web-delivered intervention trial results on ACT vs. Smokefree.gov for smoking cessation , we estimated that the mean number of times participants opened SmartQuit would be 9.02 for ACT and 5.46 for QuitGuide. Based on these estimates, there was 80% power to detect a significant difference in number of app openings with a sample size of 196. 
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Two-mo nth Fol low-up Survey
Mail not deli vera ble: 1 Non-response to foll ow-up : 13 Complet ed survey: 84 Included in fi nal analysi s: 84 In contrast, the study was not powered to show differences in quit rates, but rather to provide an estimate of the effect size for smartphone-delivered ACT.
Recruitment
Recruitment occurred from March to May 2013. Based on prior success in national recruitment for a web-delivered trial , we used both web-based and traditional methods of recruitment. Recruitment sources were: 39% from Facebook ads, 38% from press-release generated media (13% TV, 10% radio, 8% websites, 7% newspaper), and 23% from other sources (7% Google ads, 5% search engine results, 4% fhcrc.org, 7% other). Participants were directed to the study's recruitment webpage. Repeat logins from the same IP address were recorded and excluded. As shown in Fig. 1 , 738 completed the online screening survey, of whom 400 were eligible and 340 consented online. Of those, 205 completed the baseline survey and phone call to confirm study interest. These 205 participants were emailed a link allowing them to enroll in the study. All 196 (98 per arm) who clicked on this link were randomized into the trial. They were provided instructions for downloading and opening their randomly assigned app. The proportions of selfand criterion-driven exclusions from initial screening through randomization (see Fig. 1 ) were very similar to our web-delivered intervention trial , and a large web-based smoking cessation trial that used recruitment methods similar to the current study (Muñoz et al., 2006) .
Randomization
We stratified randomization on two known predictors of cessation: nicotine dependence [heaviness smoking index cut off score of 4; Heatherton et al., 1989 ] and motivation to quit [commitment to quitting scale cutoff score of 4; Kahler et al., 2007] . The two conditions were balanced at baseline on all measured characteristics (p-value average: .59; all p-values > .05).
Interventions
The two interventions were evaluated over the eight weeks following randomization, during which participants could access their assigned app as often as they wished. All app content was available for participants to use at any time. Eight identical weekly email reminders were sent to all participants following randomization in order to prompt use of the app.
SmartQuit
SmartQuit content was adapted from our web and telephonebased ACT interventions (Bricker et al., 2010 and developed into a self-paced intervention program. SmartQuit included the following features: (1) "Staying Motivated" focuses on ACT valuesbased motivations to quit via testimonials of former smokers describing how quitting smoking has helped them do things that deeply matter them (e.g., spend quality time with children) and also shows photos uploaded by users to remind them why they are quitting; (2) "My Quit Plan," helps users develop a personalized quit plan, identify social support for quitting, and provides information on selecting FDA-approved medications for quitting smoking. Based on ACT, the plan includes a key step of naming values guiding quitting (e.g., quitting because I love my daughter) and uploading photos symbolizing that value (e.g., a picture of my daughter); (3) "Having an Urge" teaches a set of ACT audio and text-based acceptance skills presented as separate tools for coping with cravings to smoke; (4) "I Slipped" teaches ACT skills in self-compassion for recovering from smoking lapses and the self-judgments that often accompany them, and (5) "Tracking" lets users record the number of times they allowed an urge to pass without smoking (the key to learning acceptance) and the number of times they practice one of the program's exercises. Tracking also includes self-monitoring of each cigarette smoked and use of medications to aid cessation. On the bottom of the main menu, participants can select to view and update their quit plan, view their progress in the "Progress" section with simple graphs, receive graphic rewards for their progress (e.g., a badge), or share their progress via Facebook, Twitter, email, or text message.
When a functional version of SmartQuit was completed, we conducted evaluations for usability with eight participants. Participants were instructed to download SmartQuit onto their iPhone and complete a set of eight tasks that tested various aspects of the application's functionality (e.g., reviewing an exercise, using the tracking feature, reviewing their progress). The first four participants were internal team members who directly noted their identified errors in a log and suggested changes to improve usability. The second set of four participants were adult, community-recruited smokers who wanted to quit. For the external users, their use of the app was video recorded, and were asked to use the think-aloud technique to verbalize their experience of the app in real time. Members of the research team viewed these videos and noted errors and suggested changes onto a spreadsheet that was emailed to the programming team. Results of these tests lead to the following three classes of corrections: (1) logic/flow errors (e.g., buttons lead to the wrong screen), (2) content (e.g., text too wordy), and (3) aesthetics (e.g., fonts too small). These corrections yielded the final version of SmartQuit used in the trial. A flow chart of SmartQuit (see Fig. 2 ) shows the structure of the app and its specific features.
QuitGuide
The National Cancer Institute's "QuitGuide" was the comparison app. QuitGuide was selected for the following reasons. First, it's one of the few apps with content that follows USCPG (Fiore et al., 2008) . Second, its content and structure is directly based on Smokefree.gov, the most accessed cessation website in the world. Since 2006, it remains the number one website on Internet searches, with over 1.8 million US visitors in 2013 (E. Augustson, personal communication, March 4, 2014). Smokefree.gov has the highest user satisfaction rates of all non-profit websites for smoking cessation (Etter, 2006) , and has 7-10% quit rates, consistent with other cessation websites not offering pharmacotherapy (Civljak et al., 2010; Hutton et al., 2011; Shahab and McEwen, 2009) . Finally, QuitGuide's content is non-proprietary and free to the public, thereby providing maximal transparency, accessibility, and replicability.
QuitGuide has these features: (1) "Thinking about quitting" focuses on reason-based motivations to quit by encouraging users to list reasons for quitting and providing information on the health consequences of smoking and quitting; (2) "Preparing to Quit," helps users develop a personalized quit plan, identify social support for quitting, and provides information on FDA-approved medications for quitting smoking; (3) "Quitting" teaches skills for avoiding cravings to smoke, such as finding replacement behaviors (e.g., chewing on carrot sticks) and staying busy; (4) "Staying Quit" presents skills for coping with slips via fighting cravings and trying to be positive. Users can share QuitGuide's content via Facebook, Twitter, or email.
Follow-up data collection
We administered a two-month post randomization follow-up survey. To maximize retention, we sequentially timed the administration of separate survey modalities until the surveys were completed: first via the web, then by telephone, and then by mail. Participants were compensated $25 for completing the survey. The achieved retention rate of 84% was much higher than the 54% typically obtained in web-based cessation trials (Civljak et al., 2010; Shahab and McEwen, 2009 ). Retention did not differ between study arms (p = 0.56).
Measures
Participant baseline characteristics: Participants reported at the baseline assessment a variety of demographics as well as smoking in the social environment. Nicotine dependence at baseline was measured with the two-item Heaviness Smoking Index from the Fagerström Test for Nicotine Dependence (Heatherton et al., 1991) .
Treatment satisfaction: Treatment satisfaction at the two-month follow-up was measured with a brief survey. A sample item was: "How useful were your program's skills exercises for quitting smoking?" Response choices ranged from "Not at all" (1) to "Very much" (5).
Utilization: At the two-month follow-up, participants selfreported the number of times they opened their assigned app. Self-reports of utilization were necessary because, for technical reasons, automatic recording of this information was not possible for QuitGuide.
ACT theory-based acceptance process: The willingness to experience and not act on physical cravings to smoke (i.e., acceptance) was measured at baseline and two-month follow-up using a nineitem subscale of the Avoidance and Inflexibility Scale [adapted from (Gifford et al., 2004) ]. The psychometric properties of the AIS have been previously reported in our research . Response choices for each item ranged from "Not at all" (1) to "Very willing" (5). Scores were derived by averaging the items.
Thirty-day point prevalence cessation outcome at two-month follow-up: For scientific rigor and comparability with other lowintensity intervention trials (Hutton et al., 2011; Stead et al., 2013) , the cessation outcome was thirty-day point prevalence abstinence (i.e., no smoking at all in the past thirty days). Smoking status was self-reported. Due to cost and low demand characteristics for false reporting, the SRNT Subcommittee on Biochemical Verification recommends biochemical confirmation is unnecessary in population-based studies with limited face-to-face contact and studies where the optimal data collection methods are through the mail or telephone (Benowitz et al., 2002) . Self-reported smoking is a standard method for assessing the efficacy of low-intensity interventions (Hutton et al., 2011; Stead et al., 2013) .
Statistical analyses
Demographic characteristics, smoking behavior, mental health measures (e.g., depression) and ACT theory-based process measures at baseline were compared between study groups using two sample t-tests for continuous variables and Fisher's exact test for binary variables. We used univariate logistic regression to test whether any of these factors predicted two-month retention. All participants were analyzed in the study arm to which they were randomized.
Logistic and linear regression was used to compare the two treatments on participant satisfaction, utilization of the app, and smoking cessation outcomes. Analyses of follow-up data were restricted to the population of participants who provided twomonth follow-up data (i.e., complete cases). We did not use the worst-case scenario assumption that non-respondents were still smoking (i.e., missing = smoking) because such imputation has been shown to result in biases in effect size estimates, and may lead either to (1) reduced statistical power and increased type II error, or (2) underestimation of variance and increased type I error, depending on the rate of non-response in each study group and the smoking cessation rate of respondents (Hallgren and Witkiewitz, 2013; Nelson et al., 2009 ). ACT theory-based acceptance outcomes were compared using linear regression models and t-tests. Logistic regression was also used to examine whether the acceptance score at follow-up was associated with 30-day PPA at two-months. All regression models included as covariates any variables that differed between study arms at baseline or that predicted follow-up retention (p < 0.10). Statistical analyses were completed using R 2.15.3. (R Core Team, 2013) .
Results
Baseline balance and follow-up retention
Demographic characteristics, smoking behavior, and ACT theory-based measures were balanced between treatment groups at baseline, with the exception of race (Table 1) . More participants identified themselves as Caucasian in the QuitGuide arm than in the ACT arm (94% vs. 85%, p = 0.06). The overall retention rate at twomonth follow-up was 84% and did not differ between study groups (p = 0.56). Some baseline characteristics were predictive of twomonth retention, including higher educational attainment, lower nicotine dependence score, light smoking, not smoking within 5 min of waking, and living with a partner who smokes (all p < 0.10).
Participant utilization and satisfaction
As shown in Table 2 , SmartQuit participants self-reported opening their assigned app, on average, 37 times compared to 15 times for QuitGuide (p = 0.0001). SmartQuit participants reported generally higher satisfaction: 85% reported their app was organized (vs. 67% for QuitGuide; p = 0.006), 53% reported it was useful for quitting (vs. 38% for QuitGuide; p = 10), and 59% were satisfied overall (vs. 45% for QuitGuide; p = 0.14).
Smoking cessation
SmartQuit had 62% to 88% descriptively higher rates of quitting, though there were wide 95% confidence intervals for the quit rate point estimates. Specifically, for all randomized participants (n = 196), the quit rates were 13% (95% CI: 6-22%) in SmartQuit vs. 8% (95% CI: 3-16%) in QuitGuide (OR = 2.7; 95% CI = 0.8-10.3). Among those at baseline scoring below the median on acceptance of cravings (n = 88), the quit rates were 15% (95% CI: 6-28%) in SmartQuit vs. 8% (95% CI: 2-20%) in QuitGuide (OR = 2.9; 95% CI = 0.6-20.7). Among those at baseline who were heavy smokers (i.e., at least a pack a day; n = 35), the quit rates were 11% (95% CI: 1-33%) in SmartQuit vs. 6% (95% CI: 0-30%) in QuitGuide (OR = 1.8; 95% CI = 0.1-53.3). Excluding all 12 participants who enrolled in another smoking cessation program during the trial (all 12 were in the QuitGuide arm), the quit rates were 13% (95% CI: 6-22%) in SmartQuit vs. 5% (95% CI: 1-13%) in QuitGuide (OR = 2.7; 95% CI = 0.8-10.0). b p-Values assess whether or not baseline characteristics were predictive of 2-month retention. The p-values were generated for each variable using univariate logistic regression models predicting an indicator of 2-month retention.
c Response choices for each item ranged from "Not at all" (1) to "Very willing" (5). Scores were derived by averaging the items.
Acceptance of cravings
From baseline to the two-month follow-up, there was an increase in acceptance of cravings in the SmartQuit arm (p < 0.04), but not in the QuitGuide arm (p = 0.15). Higher acceptance of cravings was strongly associated with 30-day point prevalence abstinence at the two-month follow-up (OR = 6.1; 95% CI = 3.0-15.2).
Discussion
This study addressed the dual needs for innovative theorybased intervention content and controlled trials to evaluate the efficacy of apps for smoking cessation. Accordingly, the aims were to determine (1) trial design feasibility, (2) participant receptivity and satisfaction, (3) preliminary cessation outcomes overall and for two key subgroups (heavy smokers and low acceptors of cravings), and (4) potential impact on theory-based acceptance of cravings to smoke. In general, the results supported all four aims.
Design feasibility
The enrollment sources and eligibility criteria provided assurances that study enrollment was feasible and timely. The outcome data collection protocol yielded a strong overall retention rate of 84%, much higher than the 54% typically obtained in comparable web-delivered cessation trials (Hutton et al., 2011; Shahab and McEwen, 2009 ).
Participant receptivity and satisfaction
SmartQuit participants opened their app 2.5 times more often than QuitGuide participants. This result, consistent with our trial of web-delivered ACT for smoking cessation , suggests that SmartQuit content was more engaging than QuitGuide content. The comparatively higher level of satisfaction for SmartQuit than for QuitGuide is consistent with the satisfaction results in our face-to-face, telephone, and web-based ACT intervention trials (Bricker et al., 2010 (Bricker et al., , 2014 Hernandez-Lopez et al., 2009) . At the same time, we see room for improvement in user satisfaction. For example, we are currently conducting research showing which features of SmartQuit were most popular and which were most predictive of the two-month smoking cessation outcome (Heffner et al., in review) . These results will inform design changes for the next version of SmartQuit. During this process, we will conduct additional iterations of user-centered design tests in order to improve the user experience, and thereby their satisfaction with the app.
Quit rates overall and among key subgroups
Tests of the encouraging quit rates are naturally underpowered because this was a pilot trial. Indeed, the 95% confidence intervals for the point estimates of quit rates were wide. But if proven definitive, the overall effect size would have high public health significance. For example, if the quit rates were 13% vs. 8%, then for every 20 smokers, SmartQuit would yield one more person who quits as compared to using QuitGuide [number needed to treat [NNT] = 20; West, 2007] . When scaled to a population level, the impact is high. For example, for every 1,000,000 smokers reached, an additional 50,000 adults would quit smoking by using SmartQuit as compared to using QuitGuide. The quit rate differences between the arms were more striking among the two subgroups we explored-descriptively about 80% to 90% higher quit rates. The effects among the low acceptance subgroup fit the ACT theoretical model, which suggests the treatment would be most beneficial for people who lack skills in accepting their cravings to smoke. The result for heavy smokers is also important because this group has very low quit rates and, thus, their morbidity and mortality rates are strikingly high (Fagan et al., 2004) .
Impact on acceptance of cravings
The results on SmartQuit's baseline to follow-up changes in acceptance of cravings are important for several reasons. First, from an intervention design perspective, they suggest that the SmartQuit intervention protocol impacted its intended clinical process target. Second, the results comport with the ACT theoretical model of acceptance as it applies to smoking cessation, namely that acceptance of cravings is an underlying process of smoking cessation. Finally, the results are highly consistent with all of the previous studies of ACT for smoking cessation (Bricker et al., 2010 (Bricker et al., , 2014 Gifford et al., 2004 Gifford et al., , 2011 Hernandez-Lopez et al., 2009 ).
Limitations
The study has important limitations. As a pilot randomized trial, the study's sample size was not powered to detect statistically significant differences in quit rates or to conduct formal mediation analysis of hypothesized treatment effects. Moreover, there is substantial relapse that naturally occurs after a two-month followup (Hollis et al., 2007; Stead et al., 2013) and therefore a longer term follow-up (e.g., twelve months) is recommended. Utilization data were self-reported because, for technical reasons, automatic recording of this information was not possible for QuitGuide. A future full-scale trial should use automatic recording of utilization data. Finally, we relied exclusively on self-reported abstinence in our estimate of 30-day point prevalence abstinence. However, expert consensus suggests that biochemical verification of abstinence is impractical and unnecessary in studies similar to the current one (Benowitz et al., 2002) .
Future directions
The study results suggest four lines of future research: (1) provide a definitive test of the effectiveness for smoking cessation of smartphone-delivered SmartQuit compared with QuitGuide-an app that follows US Clinical Practice Guidelines; (2) demonstrate that the smoking cessation outcomes of SmartQuit, but not QuitGuide, are mediated by acceptance of internal cues to smoke (sensations, emotions, and thoughts), a psychological measure that is central to the theoretical model underlying ACT; (3) determine the comparative cost-effectiveness of SmartQuit vs. QuitGuide; and (4) further explore the effectiveness for smoking cessation of SmartQuit vs. QuitGuide among these baseline subgroups, including those who avoid cravings and heavy smokers.
Conclusion
ACT is feasible to deliver by smartphone app, acceptable to the majority of users, and shows promising quit rates compared to an app that follows US Clinical Practice Guidelines. As results were limited by the pilot design (e.g., small sample), a full-scale efficacy trial is now needed to further stimulate research on smartphone apps for smoking cessation.
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